Evidence map›Paper›PMID 35768847›Full record

ArticleTranslational neurodegeneration2022

Retraction Note: Alpha-synuclein overexpression in the olfactory bulb initiates prodromal symptoms and pathology of Parkinson's disease.

Haichen Niu, Lingyu Shen, Tongzhou Li, Chao Ren, Sheng Ding, Lei Wang, Zhonghai Zhang, Xiaoyu Liu, Qiang Zhang, Deqin Geng and 2 more

RetractedOpen access · goldAbstract readRetraction Notice
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational neurodegeneration, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Progress of Immunotherapies in Parkinson's Disease.CNS neuroscience & therapeutics · 2026
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Haichen Niu *Department of Genetics, Xuzhou Medical University, Xuzhou, 221004, China.
Lingyu Shen *Department of Epidemiology and Health Statistics, Xuzhou Medical University, Xuzhou, 221004, China.
Tongzhou Li *Department of Epidemiology and Health Statistics, Xuzhou Medical University, Xuzhou, 221004, China.
Chao Ren *Department of Neurology, Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, 264000, China.
Sheng DingDepartment of Epidemiology and Health Statistics, Xuzhou Medical University, Xuzhou, 221004, China.
Lei WangDepartment of Genetics, Xuzhou Medical University, Xuzhou, 221004, China.
Zhonghai ZhangDepartment of Genetics, Xuzhou Medical University, Xuzhou, 221004, China.
Xiaoyu LiuCollege of Medicine, Institute for Behavioral Medicine Research, The Ohio State University, Columbus, OH, USA.
Qiang ZhangDepartment of Genetics, Xuzhou Medical University, Xuzhou, 221004, China.
Deqin GengDepartment of Neurology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221004, China. gengdeqin@hotmail.com.
Xiujuan WuDepartment of Epidemiology and Health Statistics, Xuzhou Medical University, Xuzhou, 221004, China.
Haiying LiDepartment of Pathology, Xuzhou Medical University, Xuzhou, 221004, China. lihaiying84@163.com.
Xuzhou Medical College · CNInstitute for Behavioral Medicine · USQingdao University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35768847
PMCPMC9241325
OpenAlexW4283698812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.